Domain III of the envelope protein as a dengue vaccine targetMaría G. Guzmán, Gerardo Guillén, Lisset Hermida et al.|Expert Review of Vaccines|2010Cited by 125
Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue VaccinesRoland Züst, Katja Fink, Y. T. Toh et al.|Journal of Virology|2014Cited by 86
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in miceIris Valdés, Lisset Hermida, Lídice Bernardo et al.|Virology|2009Cited by 65
INDUCTION OF NEUTRALIZING ANTIBODIES AND PARTIAL PROTECTION FROM VIRAL CHALLENGE IN MACACA FASCICULARIS IMMUNIZED WITH RECOMBINANT DENGUE 4 VIRUS ENVELOPE GLYCOPROTEIN EXPRESSED IN PICHIA PASTORISMaría G. Guzmán, Gerardo Guillén, R. Rodríguez et al.|American Journal of Tropical Medicine and Hygiene|2003Cited by 57
A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in miceLisset Hermida, Gerardo Guillén, Laura Lazo et al.|Journal of Virological Methods|2003Cited by 56